Prognosis, imatinib dose, and benefit of sunitinib in GIST: knowing the genotype

J Clin Oncol. 2008 Nov 20;26(33):5322-5. doi: 10.1200/JCO.2008.17.7725. Epub 2008 Oct 27.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Benzamides
  • Drug Resistance, Neoplasm / genetics*
  • Gastrointestinal Stromal Tumors / drug therapy*
  • Gastrointestinal Stromal Tumors / genetics*
  • Humans
  • Imatinib Mesylate
  • Indoles / therapeutic use*
  • Mutation
  • Piperazines / administration & dosage*
  • Prognosis
  • Protein Kinase Inhibitors / therapeutic use*
  • Proto-Oncogene Proteins c-kit / genetics*
  • Pyrimidines / administration & dosage*
  • Pyrroles / therapeutic use*
  • Receptor, Platelet-Derived Growth Factor alpha / genetics*
  • Sunitinib

Substances

  • Benzamides
  • Indoles
  • Piperazines
  • Protein Kinase Inhibitors
  • Pyrimidines
  • Pyrroles
  • Imatinib Mesylate
  • Proto-Oncogene Proteins c-kit
  • Receptor, Platelet-Derived Growth Factor alpha
  • Sunitinib